Experimental oral contraceptive looks promising for men

Researchers at Columbia University say they have been making distinct progress with a preclinical contraceptive pill for men. By interrupting the body's ability to process vitamin A the investigators say that they were able to prevent production of sperm without interfering with long-term fertility. The body does require vitamin A for vision, but the investigators say their approach shouldn't interfere with anyone's eyesight. The next step will be testing the treatment in men. Report

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.